Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06408454
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2024-04-15
Brief Title:
Interleukin- 17 IL-17 Bcl-3 and NF-kappa-B Inhibitor Zeta IκBζ Expression Levels in the Psoriasis Patients
Sponsor:
Organization:
Kahramanmaras Sutcu Imam University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Gingival crevicular fluid
Enrollment Count:
12
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 106855 |
Who Masked List: